Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma

Published:2021-01-11 Issue:3 Volume:39 Page:274-283
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Kim Yuna¹,Lee Han Ah²,Lee Jae Seung¹,Jeon Mi Young¹,Kim Beom Kyung¹³⁴,Park Jun Yong¹³⁴,Kim Do Young¹³⁴,Ahn Sang Hoon¹³⁴,Um Soon Ho²,Seo Yeon Seok²,Kim Seung Up¹³⁴

Affiliation:

1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

2. Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea

3. Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea

4. Yonsei Liver Center, Severance Hospital, Seoul, Korea

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2020.1870126

Reference37 articles.

1. Hepatocellular Carcinoma

2. Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma

3. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

4. Bridging to liver transplantation in HCC patients

5. Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy;Annals of Hepatology;2025-01

2. Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization;Cancers;2021-12-23